サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405768

体外肺モデルの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

In Vitro Lung Model Market Size, Share & Trends Analysis Report By Type (2D Model, 3D Model), By Application (Physiological Research, 3D Model Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
体外肺モデルの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2023年12月04日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外肺モデル市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の体外肺モデル市場規模は2030年までに9億4,810万米ドルに達し、2024年から2030年までのCAGRは17.4%で成長すると予測されています。

市場成長を促進する要因としては、動物実験モデルの代替品作りに重点が置かれるようになっていること、ここ数年の呼吸器関連疾患の世界の増加などが挙げられます。試験管内肺モデルは、研究者が特定の呼吸器疾患を再現し、潜在的な治療オプションの開発のためにこれらの疾患の細胞および分子特性を密接に模倣するのに役立ちます。このように、疾患のモデル化は試験管内肺モデルの全体的な成長に寄与しています。さらに、米国動物愛護協会（HSUS）の報告によれば、米国では毎年約5,000万匹の動物が実験に使用されています。動物に対する残酷な行為を軽減するために、動物福祉法（AWA）は動物に対する有害な実験を減らすことを目的とした規制を設けています。

このように、ここ数年、研究分野における動物の倫理的扱いに関する世界の認識と関心が顕著になってきています。この強調は、試験管内肺モデルに対する世界の需要の増加に寄与しています。さらに、動物を用いた維持や試験には費用がかかるが、in vitroモデルを用いれば、特に化合物や化学物質のハイスループットスクリーニングにおいて、費用対効果が高くなります。この費用対効果は、予算が限られている研究者や組織にとって魅力的であり、in vitroモデルを動物実験に代わる信頼できるものにしています。主要参入企業は、世界の足跡と製品ポートフォリオを拡大するため、パートナーシップ、M&A、契約、製品発表など、さまざまな戦略を採用しています。例えば、2023年6月、AlveoliX社は、革新的な3D構造機能を含む新しい臓器オンチップシステムを発表し、あらゆる臓器の模倣をより便利にしています。

体外肺モデル市場レポートハイライト

  • 利便性、効率性、包括的な性質により、2Dモデルタイプが2023年の市場を独占。
  • 創薬・毒性研究用途は、医薬品研究開発の初期段階で極めて重要な役割を果たすため、2023年の市場を独占しました。
  • 最終用途別では、医薬品開発・研究における重要な役割から、製薬・バイオテクノロジー企業が2023年の市場を独占しました。
  • 北米は、同地域に主要企業や学術研究機関が存在するため、2023年の業界を支配しました。
  • 同市場で事業を展開する主要企業は、市場ポジションを維持するため、製品の上市、提携、地理的拡大に絶えず注力しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 タイプビジネス分析

  • 体外肺モデル市場：製品の変動分析
  • 2Dモデル
    • 2Dモデル市場、2018年～2030年
  • 3Dモデル
    • 3Dモデル市場、2018年～2030年

第5章 用途ビジネス分析

  • 体外肺モデル市場：用途変動分析
  • 創薬・毒性研究
    • 創薬・毒性研究市場、2018年～2030年
  • 生理学的調査
    • 生理学的調査市場、2018年～2030年
  • 3Dモデル開発
    • 3Dモデル開発市場、2018年～2030年
  • その他
    • その他市場、2018年～2030年

第6章 最終用途ビジネス分析

  • 体外肺モデル市場：最終用途時の変動分析
  • 学術研究機関
    • 学術研究機関市場、2018年～2030年
  • 製薬会社・バイオテクノロジー会社
    • 製薬・バイオテクノロジー企業の市場、2018年～2030年
  • その他
    • その他市場、2018年～2030年

第7章 地域ビジネス分析

  • 地域別の体外肺モデル市場シェア、2023年および2030年
  • 北米
    • 北米の体外肺モデル市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の体外肺モデル市場、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の体外肺モデル市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの体外肺モデル市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの体外肺モデル市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2023年
  • 企業プロファイル
    • Epithelix
    • MATTEK
    • MIMETAS
    • Lonza
    • Emulate
    • AlveoliX AG
    • InSphero
    • CN Bio Innovations Ltd
    • ATTC Global
    • TissUse GmbH
図表

List of Tables

  • TABLE 1 Global In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 2 Global In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 3 Global In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 4 Global In Vitro Lung Model market, by region, 2018 - 2030 (USD Million)
  • TABLE 5 North America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 6 North America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 7 North America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 8 North America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 13 Canada In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 14 Canada In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 15 Europe In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 16 Europe In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 17 Europe In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 18 Europe In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 UK In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 20 UK In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 21 UK In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 22 Germany In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 23 Germany In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 24 Germany In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 25 France In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 26 France In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 27 France In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Italy In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 29 Italy In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Italy In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 31 Spain In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 32 Spain In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Spain In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Sweden In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 35 Sweden In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 36 Sweden In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 37 Norway In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 38 Norway In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Norway In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 40 Denmark In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 41 Denmark In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 42 Denmark In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Asia Pacific In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 Japan In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 48 Japan In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 49 Japan In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 China In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 51 China In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 52 China In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 53 India In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 54 India In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 55 India In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Australia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 57 Australia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 58 Australia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 62 Thailand In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 63 Thailand In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Thailand In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 65 Latin America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 66 Latin America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 67 Latin America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 69 Brazil In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 70 Brazil In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 71 Brazil In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 72 Mexico In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 73 Mexico In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 74 Mexico In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 75 Argentina In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 76 Argentina In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 77 Argentina In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 78 MEA In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 79 MEA In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 80 MEA In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 81 MEA In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 82 South Africa In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 83 South Africa In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 84 South Africa In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 85 Saudi Arabia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 86 Saudi Arabia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 87 Saudi Arabia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 89 UAE In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 92 Kuwait In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 93 Kuwait In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 94 Key companies undertaking acquisitions
  • TABLE 95 Key companies launching new products/services
  • TABLE 96 Key companies undertaking collaborations and partnerships
  • TABLE 97 Key companies undertaking other initiatives

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 In Vitro Lung Model market segmentation
  • FIG. 8 Market snapshot, 2023
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global In Vitro Lung Model Market: Type movement analysis
  • FIG. 15 Global In Vitro Lung Model Market, for 2D Model, 2018 - 2030 (USD Million)
  • FIG. 16 Global In Vitro Lung Model Market, for 3D Model, 2018 - 2030 (USD Million)
  • FIG. 17 Global In Vitro Lung Model Market: application movement analysis
  • FIG. 18 Global In Vitro Lung Model Market, for drug discovery and toxicology studies, 2018 - 2030 (USD Million)
  • FIG. 19 Global In Vitro Lung Model Market, for 3D model development, 2018 - 2030 (USD Million)
  • FIG. 20 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
  • FIG. 21 Global In Vitro Lung Model Market: end-use movement analysis
  • FIG. 22 Global In Vitro Lung Model Market, for academic research institutes, 2018 - 2030 (USD Million)
  • FIG. 23 Global In Vitro Lung Model Market, for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 24 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
  • FIG. 25 Regional marketplace: Key takeaways
  • FIG. 26 Regional outlook, 2023 & 2030
  • FIG. 27 Global In Vitro Lung Model Market: Region movement analysis
  • FIG. 28 North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 29 U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 30 Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 31 Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 32 Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 33 UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 34 France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 35 Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 36 Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 37 Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 38 Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 39 Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 40 Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 41 Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 42 China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 43 India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 44 Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 45 South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 46 Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 47 Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 48 Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 49 Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 50 Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 51 Middle East and Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 52 South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 53 Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 54 UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 55 Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-159-8

In Vitro Lung Model Market Growth & Trends:

The global in vitro lung model market size is expected to reach USD 948.1 million by 2030, growing at a CAGR of 17.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth include increasing emphasis on creating substitutes for animal testing models, and recent global rise in respiratory-related disorders over the past few years. In vitro lung models help researchers replicate specific respiratory diseases, closely mimicking the cellular and molecular characteristics of these disorders for the development of potential treatment options. Thus, disease modeling contributes to the overall growth of in vitro lung models. Furthermore, as per The Humane Society of the United States (HSUS) report, about 50 million animals are used in experiments each year in the U.S. To mitigate cruelty to animals, the Animal Welfare Act (AWA) has established regulations aimed at reducing harmful experiments on animals.

Thus, over the past few years, there has been a notable global awareness and concern regarding the ethical treatment of animals in the research field. This emphasis has contributed to the increased demand for in vitro lung models worldwide. Furthermore, maintaining and testing on animals is expensive, whereas the use of in vitro models can be more cost-effective, especially for high-throughput screening of compounds and chemicals. This cost-effectiveness is appealing to researchers and organizations with limited budgets, making in vitro models a dependable alternative to animal testing. Key participants are adopting various strategies including partnerships, mergers & acquisitions, agreements, and product launches, to expand their global footprints and product portfolio. For instance, in June 2023, AlveoliX introduced a new organ-on-chip system that includes innovative 3D structure features, making mimicking any organ more convenient.

In Vitro Lung Model Market Report Highlights:

  • 2D model type dominated the market in 2023 due to their convenience, efficiency, and comprehensive nature
  • The drug discovery & toxicology studies application segment dominated the market in 2023 as these models play a pivotal role in the early stages of pharmaceutical research & development
  • Based on end-use, the pharmaceutical & biotechnology companies segment dominated the market in 2023 due to their critical role in drug development & research
  • North America dominated the industry in 2023 owing to the presence of key players as well as academic research institutions in the region
  • Key players operating in the market constantly focus on product launches, partnerships, and geographical expansions to maintain their market position

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Application & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Application & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of respiratory diseases
      • 3.2.1.2. Advancement in cell culture technology
      • 3.2.1.3. Increasing number of research activities being done towards pulmonary drug development
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professional
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. In Vitro Lung Model Market: Product Movement Analysis
  • 4.2. 2D Model
    • 4.2.1. 2D Model Market, 2018 - 2030 (USD Million)
  • 4.3. 3D Model
    • 4.3.1. 3D Model Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. In Vitro Lung Model Market: Application Movement Analysis
  • 5.2. Drug discovery and Toxicology Studies
    • 5.2.1. Drug discovery and toxicology studies Market, 2018 - 2030 (USD Million)
  • 5.3. Physiological Research
    • 5.3.1. Physiological Research Market, 2018 - 2030 (USD Million)
  • 5.4. 3D Model Development
    • 5.4.1. 3D Model Development Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. In Vitro Lung Model Market: End-use Movement Analysis
  • 6.2. Academic Research Institutes
    • 6.2.1. Academic Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.3. Pharmaceutical and Biotechnology Companies
    • 6.3.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. In Vitro Lung Model Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Epithelix
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. MATTEK
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. MIMETAS
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Emulate
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. AlveoliX AG
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. InSphero
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. CN Bio Innovations Ltd
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. ATTC Global
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. TissUse GmbH
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives